A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo

被引:555
作者
Taylor, PR
Carugati, A
Fadok, VA
Cook, HT
Andrews, M
Carroll, MC
Savill, JS
Henson, PM
Botto, M
Walport, MJ
机构
[1] Hammersmith Hosp, Imperial Coll, Sch Med, Div Med,Rheumatol Sect, London W12 0NN, England
[2] Hammersmith Hosp, Imperial Coll, Sch Med, Dept Histopathol, London W12 0NN, England
[3] Natl Jewish Med Res Ctr, Dept Pediat, Denver, CO 80206 USA
[4] Univ Nottingham Hosp, Div Renal & Inflammatory Dis, Nottingham NG7 2UH, England
[5] Harvard Univ, Sch Med, Dept Pediat, Ctr Blood Res, Boston, MA 02165 USA
[6] Univ Edinburgh, Sch Med, Ctr Inflammat Res, Edinburgh EH3 9YW, Midlothian, Scotland
基金
英国惠康基金;
关键词
systemic lupus erythematosus; complement deficiency; C1q; transgenic mice; apoptosis;
D O I
10.1084/jem.192.3.359
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The strongest susceptibility genes for the development of systemic lupus erythematosus (SLE) in humans are null mutants of classical pathway complement proteins. There is a hierarchy of disease susceptibility and severity according to the position of the missing protein in the activation pathway, with the severest disease associated with C1q deficiency. Here we demonstrate, using novel in vivo models of apoptotic cell clearance during sterile peritonitis, a similar hierarchical role for classical pathway complement proteins in vivo in the clearance of apoptotic cells by macrophages. Our results constitute the first demonstration of an impairment in the phagocytosis of apoptotic cells by macrophages in vivo in a mammalian system. Apoptotic cells are thought to be a major source of the autoantigens of SLE, and impairment of their removal by complement may explain the link between hereditary complement deficiency and the development of SLE.
引用
收藏
页码:359 / 366
页数:8
相关论文
共 44 条